Jason B Alarcon
Overview
Explore the profile of Jason B Alarcon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
276
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gurtner G, Garcia A, Bakewell K, Alarcon J
Int Wound J
. 2019 Nov;
17(1):55-64.
PMID: 31729833
Most chronic wounds are related to comorbidities, for which no clinical trials are performed. This retrospective propensity matched-cohort study examined data from 2 074 000 lower extremity wounds across 644...
2.
Huang J, DSouza A, Alarcon J, Mikszta J, Ford B, Ferriter M, et al.
Clin Vaccine Immunol
. 2009 Mar;
16(5):719-25.
PMID: 19261773
The potential use of Yersinia pestis as a bioterror agent is a great concern. Development of a stable powder vaccine against Y. pestis and administration of the vaccine by minimally...
3.
Morefield G, Tammariello R, Purcell B, Worsham P, Chapman J, Smith L, et al.
J Immune Based Ther Vaccines
. 2008 Sep;
6:5.
PMID: 18768085
Background: Combination vaccines reduce the total number of injections required for each component administered separately and generally provide the same level of disease protection. Yet, physical, chemical, and biological interactions...
4.
Alarcon J, Hartley A, Harvey N, Mikszta J
Clin Vaccine Immunol
. 2007 Mar;
14(4):375-81.
PMID: 17329444
Recent clinical studies have suggested that, for certain strains of influenza virus, intradermal (i.d.) delivery may enable protective immune responses using a lower dose of vaccine than required by intramuscular...
5.
Dean C, Alarcon J, Waterston A, Draper K, Early R, Guirakhoo F, et al.
Hum Vaccin
. 2006 Oct;
1(3):106-11.
PMID: 17012854
Flaviviral diseases such as yellow fever, Japanese encephalitis (JE) and dengue hemorrhagic fever cause enormous morbidity and mortality worldwide. There is an urgent need for alternative technologies for mass vaccination...
6.
Mikszta J, Sullivan V, Dean C, Waterston A, Alarcon J, Dekker 3rd J, et al.
J Infect Dis
. 2004 Dec;
191(2):278-88.
PMID: 15609239
A new anthrax vaccine under clinical investigation is based on recombinant Bacillus anthracis protective antigen (rPA). Here, we investigated microneedle-based cutaneous and nasal mucosal delivery of rPA in mice and...
7.
Mikszta J, Alarcon J, Brittingham J, Sutter D, Pettis R, Harvey N
Nat Med
. 2002 Apr;
8(4):415-9.
PMID: 11927950
Skin is an attractive target for delivery of genetic therapies and vaccines. However, new approaches are needed to access this tissue more effectively. Here, we describe a new delivery technology...